# Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial

> **NCT07004452** · — · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 5000 (estimated)

## Conditions studied

- Premature Coronary Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07004452
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-31
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004452, "Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07004452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*